Synexa raises awareness for Rare Diseases Day
28 February 2022 marks Rare Disease Awareness Day and here at Synexa Life Sciences we are sharing our colours to raise awareness for the rare disease community.
We at Synexa support a great deal of translational research in the Lupus space, which is driven in part by the high unmet medical of the disease. The Western Cape region of South Africa has one of the highest incidence of Lupus in the world with a strong predisposition to Lupus Nephritis (LN), a rare orphan disease.
A significant focus of our research is biomarker discovery to distinguish SLE from LN. This has included characterising immune cells, inflammatory cytokines and autoantibodies over the duration of symptomatic treatments. We have demonstrated significant differences in a number of biomarkers, capable of more closely stratifying LN from SLE patients.
We continue to strive for the better understanding of the biomarker landscape for many rare diseases, in the hope of accelerating the development of much needed therapies for millions of people.
